Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Concert Pharmaceuticals Inc. sell StockNews.com

Start price
€7.86
12.03.23 / 50%
Target price
-
12.03.24
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 12.03.24. The prediction end date can be changed by StockNews_com at any time.
Performance without dividends (%)
Name 1w
Concert Pharmaceuticals Inc. -
iShares Core DAX® 0.284%
iShares Nasdaq 100 -0.713%
iShares Nikkei 225® 0.598%
iShares S&P 500 -2.171%

Comments by StockNews_com for this prediction

In the thread Concert Pharmaceuticals Inc. diskutieren

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CNCE provided by MarketBeat